[ET Net News Agency, 3 July 2026] REMEGEN (09995) rose 10.1% to HK$88.15.
It hits an intra-day high of HK$88.15, hitting an 1-month high, breaking above the 250-D SMA of HK$85.885, and an intra-day low of HK$82.4. The total shares traded was 8.15 million, with a value of HK$692.57m. The active buy/sell ratio is 59:41, with net buying turnover of HK$116.91m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$24.84m, with volume weighted average price of HK$84.784. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$40.04m, with volume weighted average price of HK$85.523. The stock has risen a combined 18.6% over the past 2 consecutive trading days.
Basic Information| Nominal | 88.150 | % Chg | +10.12% |
| High | 88.150 | Low | 82.400 |
| Shares Tr | 8.15m | Turnover | 692.57m |
| 10-D SMA | 73.290 | %H.V | 74.950 |
| 20-D SMA | 71.795 | VWAP | 84.976 |
| 50-D SMA | 84.506 | RSI14 | 63.871 |
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is 59:41, with net buying turnover of HK$116.91m, rising a combined 18.6% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 88.15 | +10.12 |
| INNOVENT BIO (01801) | 87.20 | +2.17 |
| XTALPI (02228) | 7.86 | +5.08 |
| WUXI XDC (02268) | 61.70 | +4.93 |
| WUXI BIO (02269) | 37.54 | +4.68 |
| WUXI APPTEC (02359) | 156.30 | +2.29 |
| BEONE MEDICINES (06160) | 181.30 | +3.78 |
| SKB BIO (06990) | 494.20 | +5.69 |
| DUALITYBIO-B (09606) | 216.00 | +3.25 |
| AKESO (09926) | 101.50 | +7.07 |
(ed)
